Anaphylactic Reactions During Bee Venom Immunotherapy in the Paediatric Population.

Aim: A retrospective study will review episodes of anaphylaxis during bee venom immunotherapy (BVIT) in children, any modifications made to the dosing schedule, and the subsequent outcomes over a nine-year period in Western Australia.

Methods: Patient demographics, dose eliciting anaphylaxis during BVIT, modifications made to BVIT regimen following anaphylaxis (i.e.

A local case of fulminant primary amoebic meningoencephalitis due to Naegleria fowleri.

Primary amoebic meningoencephalitis is an extremely rare, predominantly fulminant central nervous system infection caused by the amoeba Naegleria fowleri, first described in Australia in 1965. Despite the ubiquitous presence of N. fowleri, as few as 300 cases of infection have since been reported worldwide, with a case fatality rate approaching 98%.